292 related articles for article (PubMed ID: 18621429)
41. Costs, effects and cost-effectiveness of breast cancer control in Ghana.
Zelle SG; Nyarko KM; Bosu WK; Aikins M; Niëns LM; Lauer JA; Sepulveda CR; Hontelez JA; Baltussen R
Trop Med Int Health; 2012 Aug; 17(8):1031-43. PubMed ID: 22809238
[TBL] [Abstract][Full Text] [Related]
42. Estimating the costs and health benefits of water and sanitation improvements at global level.
Haller L; Hutton G; Bartram J
J Water Health; 2007 Dec; 5(4):467-80. PubMed ID: 17878561
[TBL] [Abstract][Full Text] [Related]
43. Economic evaluation of the US Environmental Protection Agency's SunWise program: sun protection education for young children.
Kyle JW; Hammitt JK; Lim HW; Geller AC; Hall-Jordan LH; Maibach EW; De Fabo EC; Wagner MC
Pediatrics; 2008 May; 121(5):e1074-84. PubMed ID: 18450850
[TBL] [Abstract][Full Text] [Related]
44. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
45. A study on refractive errors among school children in Kolkata.
Das A; Dutta H; Bhaduri G; De Sarkar A; Sarkar K; Bannerjee M
J Indian Med Assoc; 2007 Apr; 105(4):169-72. PubMed ID: 17822183
[TBL] [Abstract][Full Text] [Related]
46. Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.
Sroczynski G; Esteban E; Conrads-Frank A; Schwarzer R; Mühlberger N; Wright D; Zeuzem S; Siebert U
Eur J Public Health; 2009 Jun; 19(3):245-53. PubMed ID: 19196737
[TBL] [Abstract][Full Text] [Related]
47. Magnitude and determinants of refractive error in Omani school children.
Khandekar RB; Abdu-Helmi S
Saudi Med J; 2004 Oct; 25(10):1388-93. PubMed ID: 15494808
[TBL] [Abstract][Full Text] [Related]
48. Prevalence and causes of functional low vision in school-age children: results from standardized population surveys in Asia, Africa, and Latin America.
Gilbert CE; Ellwein LB;
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):877-81. PubMed ID: 18326706
[TBL] [Abstract][Full Text] [Related]
49. Health and economic benefits of well-designed evaluations: some lessons from evaluating neuroblastoma screening.
Soderstrom L; Woods WG; Bernstein M; Robison LL; Tuchman M; Lemieux B
J Natl Cancer Inst; 2005 Aug; 97(15):1118-24. PubMed ID: 16077069
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of scoliosis and cost-effectiveness of screening in schools in Turkey.
Ugras AA; Yilmaz M; Sungur I; Kaya I; Koyuncu Y; Cetinus ME
J Back Musculoskelet Rehabil; 2010; 23(1):45-8. PubMed ID: 20231789
[TBL] [Abstract][Full Text] [Related]
51. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ginsberg GM; Lauer JA; Zelle S; Baeten S; Baltussen R
BMJ; 2012 Mar; 344():e614. PubMed ID: 22389347
[TBL] [Abstract][Full Text] [Related]
52. Analytical tools for planning cost-effective surveillance in Gambiense sleeping sickness.
Shaw AP; Cattand P
Med Trop (Mars); 2001; 61(4-5):412-21. PubMed ID: 11803834
[TBL] [Abstract][Full Text] [Related]
53. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
54. Human health benefits from livestock vaccination for brucellosis: case study.
Roth F; Zinsstag J; Orkhon D; Chimed-Ochir G; Hutton G; Cosivi O; Carrin G; Otte J
Bull World Health Organ; 2003; 81(12):867-76. PubMed ID: 14997239
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women.
Hwa HL; Yen MF; Lin CL; Ko TM; Hsieh FJ; Chen TH
J Eval Clin Pract; 2008 Apr; 14(2):191-7. PubMed ID: 18284525
[TBL] [Abstract][Full Text] [Related]
56. School-based screening for scoliosis: is it cost-effective?
Thilagaratnam S
Singapore Med J; 2007 Nov; 48(11):1012-7. PubMed ID: 17975691
[TBL] [Abstract][Full Text] [Related]
57. Cost-effectiveness of targeted and tailored interventions on colorectal cancer screening use.
Lairson DR; DiCarlo M; Myers RE; Wolf T; Cocroft J; Sifri R; Rosenthal M; Vernon SW; Wender R
Cancer; 2008 Feb; 112(4):779-88. PubMed ID: 18098272
[TBL] [Abstract][Full Text] [Related]
58. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
Kuznik A; Habib AG; Munube D; Lamorde M
BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
[TBL] [Abstract][Full Text] [Related]
59. Cost effectiveness analysis of a visual screening program for primary school children in Thailand.
Tengtrisorn S; Sangsupawanitch P; Chansawang W
J Med Assoc Thai; 2009 Aug; 92(8):1050-6. PubMed ID: 19694330
[TBL] [Abstract][Full Text] [Related]
60. Economic effects of echinococcosis in a disease-endemic region of the Tibetan Plateau.
Budke CM; Jiamin Q; Qian W; Torgerson PR
Am J Trop Med Hyg; 2005 Jul; 73(1):2-10. PubMed ID: 16014823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
